| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
IQ motif and Sec7 domain ArfGEF 3 | 3.9E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||||
|
nuclear RNA export factor 4 pseudogene |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
MAP7 domain containing 3 | 4.6E-10 |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||||
|
olfactory receptor family 5 subfamily M member 1 | 1.9E-03 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.450 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.470 | strong | 1.000 | 1 | 0 | 2015 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 1994 | 2018 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.400 | limited | 0 | 0 | |||||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1994 | 2001 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
group | 0.410 | None | 1.000 | 1 | 0 | 2006 | 2012 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
group | 0.650 | strong | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
atrophin 1 | 0.409 | 0.885 | 1.00 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
synaptotagmin 1 | 0.412 | 0.846 | 0.60 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
group | 0.500 | None | 0.963 | 2 | 1 | 2000 | 2020 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
SRY-box transcription factor 9 | 0.419 | 0.846 | 1.00 |
|
group | 0.310 | strong | 1.000 | 1 | 0 | 2015 | 2016 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
group | 0.410 | None | 1.000 | 1 | 0 | 2001 | 2004 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.420 | strong | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
group | 0.450 | strong | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
group | 0.430 | None | 1.000 | 1 | 0 | 1992 | 2011 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
group | 0.420 | None | 1.000 | 1 | 0 | 2014 | 2018 | ||||||||
|
bromodomain containing 4 | 0.446 | 0.885 | 1.00 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2019 | 2019 |